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ABSTRACT 
Mass-scale, intraperitoneal administration of vaccines containing mineral oil-adjuvants, has 
been common practice in salmonid aquaculture since the early 1990’s. Introduced as a 
response to the threat of disruptive outbreaks of aquatic pathogens such as Aeromonas 
salmonicida subspecies salmonicida, the causative agent of furunculosis, such formulations 
have increased the survival rates and profitability of the farming of these species. 
Nevertheless, well-documented local adverse effects, including granulomatous inflammation 
with melanisation and adhesions of the peritoneal cavity, in addition to systemic effects, have 
also been observed. Here, aiming at exploring alternatives to mineral oil-adjuvanted 
furunculosis injection vaccines, three different vaccine formulations were designed and 
administered to rainbow trout (Onchorhynchus mykiss) fry. All three formulations were based 
on whole-cell A. salmonicida subspecies salmonicida bacterin, formulated with either 
Freund’s incomplete adjuvant (FIA), dimethyldioctadecylammonium/trehalose 6,6’-
dibehenate liposomes (CAF01), or CpG oligodeoxynucleotides. Non-vaccinated, TBS-
injected and bacterin-injected groups were included as control groups. Following vaccination, 
fish were sampled in order to monitor the occurrence of adverse effects, as well as the 
development of the immunological reaction to each vaccine formulation. Finally, a 
waterborne challenge with A. salmonicida was performed to assess the protection obtained in 
each experimental group. Significant differences were observed with regards to the 
occurrence of adverse effects, both in individual scoring of adhesions and pigmentation, as 
well as in the combining Speilberg score, demonstrating a general reduction in adverse effects 
in the CpG- and CAF01-group, compared to individuals injected with the FIA-formulation. 
When analyzing serum samples, significantly elevated antibody titers were seen in all three 
experimental formulations when compared to non-vaccinated controls, and finally a 
significant, uniform protective effect was seen in all three vaccine groups.  
While this is still an ongoing study, the combination of protection from infection along with 
the reduction in adverse effects achieved by the use of liposomal and nucleotide adjuvants in 
this study, is promising with respect to alternative, low-toxicity adjuvants in aquaculture. 
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